Sarepta Therapeutics (SRPT) Profit After Tax (QoQ) (2010 - 2026)
Sarepta Therapeutics (SRPT) Profit After Tax (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.71 Bn | 1.31 Bn | 622.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 185.11% |
| Dec 31, 2025 | -715.19% |
| Sep 30, 2025 | -125.68% |
| Jun 30, 2025 | 144.00% |
| Mar 31, 2025 | -381.36% |
| Dec 31, 2024 | 373.21% |
| Sep 30, 2024 | 420.29% |
| Jun 30, 2024 | -82.11% |
| Mar 31, 2024 | -20.89% |
| Dec 31, 2023 | 211.53% |
| Sep 30, 2023 | -71.00% |
| Jun 30, 2023 | 95.37% |
| Mar 31, 2023 | -387.23% |
| Dec 31, 2022 | 58.85% |
| Sep 30, 2022 | -11.34% |
| Jun 30, 2022 | -120.41% |
| Mar 31, 2022 | 13.90% |
| Dec 31, 2021 | -153.37% |
| Sep 30, 2021 | 40.86% |
| Jun 30, 2021 | 51.33% |